Buckwheat husk extract for heart risk factors
Part of Heart & circulation clinical trials.
This trial studies whether buckwheat husk extract can improve certain heart-related measurements in people with mildly high blood pressure. It may help lower cardiovascular risk factors by affecting things like blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 20 to 65, and you can give consent to join
- Your blood pressure is in this range: top number 121–139 and bottom number 81–89
- If you can get pregnant, you are not pregnant and will use contraception during the study
- You don’t have a history of major illnesses like organ transplant, epilepsy/seizures, major liver or kidney disease, cancer, serious hormone problems, or mental illness
- You don’t have a history of alcohol or drug abuse
- You have not had major surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving early blood pressure medication to people with slightly high blood pressure (stage 1) can help prevent future heart problems. If you qualify, you may receive treatment sooner to protect your heart and brain.
This trial tests whether a grape seed extract supplement can help people with slightly high blood pressure (called high-normal) improve their heart health. It may be an option if your blood pressure is borderline and you are not taking blood pressure medications.
This trial tests whether a grape seed extract can help lower blood pressure in people with mildly high blood pressure and slightly elevated blood sugar. It's designed for adults aged 40-60 who are not on blood pressure or diabetes medications.
This early-stage trial tests a new oral medication (HS-10522) to see if it is safe and how the body handles it. It includes both healthy people and those with mild high blood pressure, and may help lower blood pressure in the future.
This early-stage trial tests a new blood pressure medication called HJB647 in Japanese adults with elevated or high blood pressure. The study aims to see if the drug is safe and how the body handles it.
This study tests whether a supplement called TUDCA can help lower blood pressure by reducing stress inside cells. It's looking for people with high-normal blood pressure who are not on many heart medications.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.